Over the past several decades, supply chain disruptions have repeatedly plagued the U.S. health care system, costing health care systems millions of dollars per year, threatening the clinical research enterprise, and most importantly, imperiling the health and lives of patients. The Committee on Security of America's Medical Supply Chain, convened by the National Academies of Sciences, Engineering, and Medicine, was charged with addressing this important issue by examining the root causes of medical product shortages and identifying ways to enhance their resilience - both in so-called normal times and during public health emergencies.
Building Resilience into the Nation's Medical Product Supply Chains outlines the committee's seven recommendations and presents a framework of protection comprising awareness, mitigation, preparedness, and response measures.
National Academies of Sciences, Engineering, and Medicine. 2022. Building Resilience into the Nation's Medical Product Supply Chains. Washington, DC: The National Academies Press. https://doi.org/10.17226/26420.
|PART I: OVERVIEW OF GLOBAL MEDICAL PRODUCT SUPPLY CHAINS||23-24|
|2 Understanding Medical Product Supply Chains||49-68|
|3 Globalization of U.S. Medical Product Supply Chains||69-94|
|4 Causes and Consequences of Medical Product Supply Chain Failures||95-134|
|PART II: MEASURES FOR ENHANCING THE RESILIENCY OF MEDICAL PRODUCT SUPPLY CHAINS||135-136|
|5 A Framework for Resilient Medical Product Supply Chains||137-162|
|6 Awareness Measures for Resilient Medical Product Supply Chains||163-182|
|7 Mitigation Measures for Resilient Medical Product Supply Chains||183-196|
|8 Preparedness Measures for Resilient Medical Product Supply Chains||197-220|
|9 Response Measures for Resilient Medical Product Supply Chains||221-238|
|Appendix A: Study Methods and Public Agendas||239-260|
|Appendix B: Summary of Recommendations from Contemporary Reports||261-276|
|Appendix C: Determining Risk Values When Evaluating Medical Product Supply Chain Resilience||277-284|
|Appendix D: Commissioned Economic Analysis||285-322|
|Appendix E: Committee and Staff Biosketches||323-334|
|Appendix F: Disclosure of Unavoidable Conflict of Interest||335-336|
The Chapter Skim search tool presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter. You may select key terms to highlight them within pages of each chapter.
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, pleaseclick here to view more information.